✦ LIBER ✦

Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy

✍ Scribed by Wendy W. Hu; Robert S. Negrin; Keith Stockerl-Goldstein; Laura J. Johnston; Judith A. Shizuru; Ruby M. Wong; Nelson J. Chao; Gwynn D. Long; Robert H. Feiner; Karl G. Blume

Book ID: 117727857
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 95 KB
Volume: 6
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(00)70053-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy with autologous hemato

High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy

✍ Bearman, S I; Vredenburgh, J J; Cagnoni, P J; Shpall, E J; Nieto, Y; Ross, M; Pe 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Repetitive high-dose therapy with periph

Repetitive high-dose therapy with peripheral blood progenitor cell (PBPC) support for metastatic (MBC) and locally advanced breast cancer

📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 244 KB

High-dose therapy with peripheral blood

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

✍ Kun-Huei Yeh; Ming-Tseh Lin; Dong-Tsamn Lin; Jih-Luh Tang; Louis-Tak Lui; Jing-F 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 577 KB

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A phase II study of two cycles of high-d

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

✍ Bashey, A; Corringham, S; Garrett, J; Lane, T A; Gilpin, E A; Corringham, R E T; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Predicting outcome based on swenerton sc

Predicting outcome based on swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

✍ Filippo Montemurro; Gabriela Rondón; Mark Munsell; Terry L Smith; Michele L Dona 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 143 KB